The Effect of Probiotics on Maintenance of Health in Pregnancy and Infants

NCT03310853 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2023-02-02

No results posted yet for this study

Summary

This phase 2 study evaluates the effect of perinatal use of probiotics on the number of diagnosed viral, bacterial and fungal infections in pregnant women and on the maintenance of a health pregnancy. In addition, the effect of probiotics intake during pregnancy and breastfeeding on the infant's overall health status will be evaluated.

Conditions

  • Pregnancy

Interventions

DIETARY_SUPPLEMENT

Probiotic

Dosing regimen of one capsule daily for a maximum of 18 weeks

OTHER

Placebo

Dosing regimen of one capsule daily for a maximum of 18 weeks

Sponsors & Collaborators

  • Clinique Ovo

    collaborator INDUSTRY
  • Lallemand Health Solutions

    lead INDUSTRY

Principal Investigators

  • Jacques Kadoch, MD · Clinique Ovo

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-23
Primary Completion
2022-05-20
Completion
2022-05-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03310853 on ClinicalTrials.gov